Multimodal imaging for a theranostic approach in a murine model of B-cell lymphoma with engineered nanoparticles

Nanomedicine: Nanotechnology, Biology and Medicine - Tập 14 - Trang 483-491 - 2018
Enza Torino1,2,3, Luigi Auletta4, Donatella Vecchione1,3, Francesca Maria Orlandella4, Giuliana Salvatore4,5, Enrico Iaccino6, Dario Fiorenza4, Anna Maria Grimaldi4, Annamaria Sandomenico7, Sandra Albanese7, Daniela Sarnataro8,9, Matteo Gramanzini7, Camillo Palmieri6, Giuseppe Scala6, Ileana Quinto6, Paolo Antonio Netti1,2,3, Marco Salvatore4, Adelaide Greco10,7,8
1Istituto Italiano di Tecnologia, IIT - Center for Advanced Biomaterials for Health Care, CABHC@CRIB, Napoli, Italia
2Centro Interdipartimentale di Ricerca sui Biomateriali, Università degli Studi di Napoli Federico II, Napoli, Italia
3Dipartimento di Ingegneria Chimica, dei Materiali e della Produzione Industriale, Università degli Studi di Napoli Federico II, Napoli, Italia
4IRCCS SDN S.p.A., Napoli, Italia
5Dipartimento di Scienze Motorie e del Benessere, Università “Parthenope”, Napoli, Italia
6Dipartimento di Medicina Sperimentale e Clinica, Università degli Studi “Magna Graecia" di Catanzaro, Catanzaro, Italia
7IBB, CNR, Napoli, Italia
8CEINGE Biotecnologie Avanzate, s.c.ar.l., Napoli, Italia
9Dipartimento di Medicina Molecolare e Biotecnologie Mediche, Università degli Studi di Napoli Federico II, Napoli, Italia
10Dipartimento di Scienze Biomediche Avanzate, Università degli Studi di Napoli Federico II, Napoli, Italia

Tài liệu tham khảo

Stevenson, 1983, Monoclonal immunoglobulin light chain in urine of patients with B lymphocytic disease: its source and use as a diagnostic aid, Br J Cancer, 47, 607, 10.1038/bjc.1983.98 Bergenbrant, 1996, Modulation of anti-idiotypic immune response by immunization with the autologous M-component protein in multiple myeloma patients, Br J Haematol, 92, 840, 10.1046/j.1365-2141.1996.419959.x Korde, 2011, Myelomagenesis: capturing early microenvironment changes, Semin Hematol, 48, 13, 10.1053/j.seminhematol.2010.11.004 Palmieri, 2010, In vivo targeting and growth inhibition of the A20 murine B-cell lymphoma by an idiotype-specific peptide binder, Blood, 116, 226, 10.1182/blood-2009-11-253617 Knittelfelder, 2009, Mimotope vaccination—from allergy to cancer, Expert Opin Biol Ther, 9, 493, 10.1517/14712590902870386 Linnemann, 2001, Mimotopes for tumor-specific T lymphocytes in human cancer determined with combinatorial peptide libraries, Eur J Immunol, 31, 156, 10.1002/1521-4141(200101)31:1<156::AID-IMMU156>3.0.CO;2-P Tumenjargal, 2003, Anti-tumor immune responses and tumor regression induced with mimotopes of a tumor-associated T cell epitope, Eur J Immunol, 33, 3175, 10.1002/eji.200324244 Leo, 2015, Characterization of self-assembled monolayers of peptide Mimotopes of CD20 antigen and their binding with rituximab, Langmuir, 31, 13764, 10.1021/acs.langmuir.5b02605 Zhao, 2017, Synthesis of BODIPY-peptide conjugates for fluorescence labeling of EGFR overexpressing cells, Bioconjug Chem, 28, 1566, 10.1021/acs.bioconjchem.7b00211 Cherry, 2006, Multimodality in vivo imaging systems: twice the power or double the trouble?, Annu Rev Biomed Eng, 8, 35, 10.1146/annurev.bioeng.8.061505.095728 Auletta, 2017, Advances in multimodal molecular imaging, Q J Nucl Med Mol Imaging, 61, 19, 10.23736/S1824-4785.16.02943-5 Liang, 2017, Activatable near infrared dye conjugated hyaluronic acid based nanoparticles as a targeted theranostic agent for enhanced fluorescence/CT/photoacoustic imaging guided photothermal therapy, Biomaterials, 132, 72, 10.1016/j.biomaterials.2017.04.006 Mulder, 2007, Magnetic and fluorescent nanoparticles for multimodality imaging, Nanomedicine (Lond), 2, 307, 10.2217/17435889.2.3.307 Talanov, 2006, Dendrimer-based nanoprobe for dual modality magnetic resonance and fluorescence imaging, Nano Lett, 6, 1459, 10.1021/nl060765q Jaffer, 2009, Optical and multimodality molecular imaging: insights into atherosclerosis, Arterioscler Thromb Vasc Biol, 29, 1017, 10.1161/ATVBAHA.108.165530 Wang, 2016, In vivo MR and fluorescence dual-modality imaging of atherosclerosis characteristics in mice using Profilin-1 targeted magnetic nanoparticles, Theranostics, 6, 272, 10.7150/thno.13350 Chen, 2017, Theranostic imaging of liver cancer using targeted optical/MRI dual-modal probes, Oncotarget, 8, 32741, 10.18632/oncotarget.15642 Greco, 2017, Advances in molecular preclinical therapy mediated by imaging, Q J Nucl Med Mol Imaging, 61, 76, 10.23736/S1824-4785.16.02944-7 Hwang, 2012, Multimodality imaging in vivo for preclinical assessment of tumor-targeted doxorubicin nanoparticles, PLoS ONE, 7, 10.1371/journal.pone.0034463 Vecchione, 2017, Hybrid Core-Shell (HyCoS) nanoparticles produced by complex coacervation for multimodal applications, Sci Rep, 7, 45121, 10.1038/srep45121 Zhou, 2016, Superstable magnetic nanoparticles in conjugation with near- infrared dye as a multimodal theranostic platform, ACS Appl Mater Interfaces, 8, 4424, 10.1021/acsami.5b11308 Kircher, 2003, A multimodal nanoparticle for preoperative magnetic resonance imaging and intraoperative optical brain tumor delineation, Cancer Res, 63, 8122 Ntziachristos, 2003, Fluorescence imaging with near-infrared light: new technological advances that enable in vivo molecular imaging, Eur Radiol, 13, 195, 10.1007/s00330-002-1524-x Ponsiglione, 2016, Impact of biopolymer matrices on relaxometric properties of contrast agents, Interface Focus, 6, 20160061, 10.1098/rsfs.2016.0061 Li, 2016, Smart hyaluronidase-actived theranostic micelles for dual-modal imaging guided photodynamic therapy, Biomaterials, 101, 10, 10.1016/j.biomaterials.2016.05.019 Gao, 2017, Tumor acidity-activatable TAT targeted nanomedicine for enlarged fluorescence/magnetic resonance imaging-guided photodynamic therapy, Biomaterials, 133, 165, 10.1016/j.biomaterials.2017.04.013